SCHEDULE 13G
Statement of Beneficial Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0000919574-26-004022
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Domicilium Capital Partners LLC | 854,973 | 19.99% |
| Daniel Simon | 854,973 | 19.99% |
| BKJLAGG, LLC | 602,266 | 14.1% |
| Domicilium Real Estate Fund III LP | 238,422 | 5.9% |
| Domicilium Real Estate Fund III GP LLC | 238,422 | 5.9% |
| MSEK Charleston LLC | 240,688 | 5.6% |
| Bold Stroke Investments, LLC | 240,688 | 5.6% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-13 SCHEDULE 13G/A · Coastlands Capital LP 9.99%
- 2026-08-14 SCHEDULE 13G · Srinivas Akkaraju 9.9%
- 2026-08-14 SCHEDULE 13G · Nantahala Capital Management, LLC 9.91%
- 2026-07-27 SCHEDULE 13G · Aberdeen Group plc 9.91%
- 2026-06-17 SCHEDULE 13G · Coastlands Capital LP 9.99%
- 2026-06-17 SCHEDULE 13G · Domicilium Capital Partners LLC 19.99%
- 2026-06-16 SCHEDULE 13G · Stonepine Capital Management, LLC 9.9%
- 2026-06-16 SCHEDULE 13G · EcoR1 Capital, LLC 9.9%
- 2026-06-15 SCHEDULE 13G · Raymond Debbane 9.99%
- 2026-06-05 SCHEDULE 13G/A · Domicilium Capital Partners LLC 4.9%
- 2026-05-29 SCHEDULE 13G/A · Coastlands Capital LP 4.99%
- 2026-05-04 SCHEDULE 13G · Domicilium Capital Partners LLC 18.6%
- 2024-08-20 SC 13D/A · Advent Life Sciences LLP 3.98%
- 2023-02-13 SC 13G/A · Roche Finance Ltd 0.1%
- 2022-02-14 SC 13G/A · Roche Finance Ltd 5.8%
- 2022-02-03 SC 13D/A · LSP V Coöperatieve U.A 3.4%
- 2021-06-29 SC 13G · Gurnet Point L.P. 5.7%
- 2021-06-14 SC 13G · Roche Finance Ltd 5.3%
- 2021-05-21 SC 13D/A · Pontifax Management 4 G.P. (2015) Ltd. 8.66%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…